Latest Bone Marrow Transplantation Stories
Kiadis Pharma, an oncology focused pharmaceutical development company, has announced that its lead product Atir has received orphan drug designation from the European Medicines Agency for the prevention of acute graft versus host disease following an allogeneic bone marrow transplantation.
AMSTERDAM, September 22 /PRNewswire/ -- Kiadis Pharma announced today that its lead product ATIR(TM) has been granted orphan drug designation (ODD) by the European Medicines Agency (EMEA) for the prevention of acute Graft versus Host Disease (GvHD) following an allogeneic bone marrow transplantation.
FAMOUS faces from Liverpool FC have pledged their support for the Sign Up For Faye campaign. The drive was inspired by eight-year-old Faye Lafferty, who died on July 30, two months after a bone marrow transplant.
A SPECIAL bone marrow clinic to recruit potential donors is being held in the ECHO'S atrium today. Between 4pm and 7pm, the Anthony Nolan Trust was due to sign up volunteer lifesavers.
By Megan Rauscher NEW YORK (Reuters Health) - Ten percent of long-term survivors of a bone marrow transplant experience impairment in functional, social and emotional areas, according to findings published in the Archives of Pediatrics and Adolescent Medicine.
Bone Marrow Transplantation is a peer-reviewed medical journal published monthly by Nature Publishing Group. As of May 2012, the editor-in-chief is J.M. Goldman (UK). The journal publishes high quality, original research that addresses all aspects of basic biology and clinical use of haemopoietic stem cell transplantation in humans. The broad scope of the journal thus encompasses topics such as stem cell biology, kinetics and cytokine control, transplantation immunology, HLA and matching...
- A volcanic mudflow.